Ou J - Search Results

1

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer.

Luo Y, Ye Y, Chen Y, Zhang C, Sun Y, Wang C, Ou J. Luo Y, et al. Among authors: ou j. Front Immunol. 2023 Mar 13;14:1140993. doi: 10.3389/fimmu.2023.1140993. eCollection 2023. Front Immunol. 2023. PMID: 36993976 Free PMC article.

2

Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China.

Jiang W, Li Y, Ou J, Wang X, Zhang C, Yi L, Xue L, Zhang M. Jiang W, et al. Among authors: ou j. Medicine (Baltimore). 2017 Oct;96(42):e8155. doi: 10.1097/MD.0000000000008155. Medicine (Baltimore). 2017. PMID: 29049198 Free PMC article.

3

Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer.

Zhang C, Li Y, Wang X, Zhang M, Jiang W, Ou J. Zhang C, et al. Among authors: ou j. Medicine (Baltimore). 2021 Apr 16;100(15):e25365. doi: 10.1097/MD.0000000000025365. Medicine (Baltimore). 2021. PMID: 33847634 Free PMC article. Clinical Trial.

4

MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study.

Jiang W, Xing XL, Zhang C, Yi L, Xu W, Ou J, Zhu N. Jiang W, et al. Among authors: ou j. Front Oncol. 2021 May 27;11:604801. doi: 10.3389/fonc.2021.604801. eCollection 2021. Front Oncol. 2021. PMID: 34123778 Free PMC article.

5

Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.

Ye Y, Luo Y, Guo T, Zhang C, Sun Y, Xu A, Ji L, Ou J, Wu SY. Ye Y, et al. Among authors: ou j. Front Endocrinol (Lausanne). 2023 Aug 4;14:1179050. doi: 10.3389/fendo.2023.1179050. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600707 Free PMC article.

6

FOXO4 suppresses cisplatin resistance of triple-negative breast cancer by inhibiting autophagy.

Zhu Y, Zhang C, Yin Q, Xu W, Luo Y, Ou J. Zhu Y, et al. Among authors: ou j. Am J Med Sci. 2024 Aug 21:S0002-9629(24)01403-4. doi: 10.1016/j.amjms.2024.08.012. Online ahead of print. Am J Med Sci. 2024. PMID: 39154963

7

Typical presentation of neurofibromatosis type I in a patient with giant cutaneous neoplasm and café au lait spots: A case report.

Zhang C, Saibaidula Y, Luo Y, Ou J. Zhang C, et al. Among authors: ou j. Biomed Rep. 2024 Dec 5;22(2):27. doi: 10.3892/br.2024.1905. eCollection 2025 Feb. Biomed Rep. 2024. PMID: 39720298 Free PMC article.

8

Acute thrombocytopenia induced by trastuzumab due to complement reaction: A case report.

Chen G, Ou J, Liu J, Liao H, Ding L, Fan P, Du G. Chen G, et al. Among authors: ou j. Front Med (Lausanne). 2022 Dec 6;9:1037493. doi: 10.3389/fmed.2022.1037493. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36561721 Free PMC article.

9

Elevated survivin mediated multidrug resistance and reduced apoptosis in breast cancer stem cells.

Yu CJ, Ou JH, Wang ML, Jialielihan N, Liu YH. Yu CJ, et al. J BUON. 2015 Sep-Oct;20(5):1287-94. J BUON. 2015. PMID: 26537077 Free article.

10

Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study.

Wang K, Ren Y, Li H, Zheng K, Jiang J, Zou T, Ma B, Li H, Liu Q, Ou J, Wang L, Wei W, He J, Ren G. Wang K, et al. Among authors: ou j. PLoS One. 2016 Mar 31;11(3):e0152312. doi: 10.1371/journal.pone.0152312. eCollection 2016. PLoS One. 2016. PMID: 27031236 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,371 results

Search Page

Filters